The consortium envisages carrying out surveillance of important bacterial, viral and parasitic infections of zoonotic as well as transboundary pathogens
The trial will be conducted across 10 sites in India
The aim is to give a fillip to R&D in the health sector to face the Covid-19 challenge
CDSCO gives the green signal as HGCO19 was safe, tolerable and immunogenic in the participants of the study
This is the world’s first Covid=19 DNA vaccine developed in partnership with DBT-BIRAC
It falls under the Department of Biotechnology - Mission Covid Suraksha Project for augmenting manufacturing capacity for Covaxin
Sickle Cell Disease Support Corner developed to create a database of individuals with sickle cell disease
CDSCO to fast-track trials and approval for COVID19 vaccine
Releasing it, Union Minister Jitendra Singh said India needs its database for Indian research and solutions.
It works as an adjunct to standard care based on robust clinical trials
Subscribe To Our Newsletter & Stay Updated
